Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Allen

Showing results (191-200 of 220) with videos related to

Pageof 22
Sort By:
Frontiers in Virology (Lausanne, Switzerland)|August 19, 2022
Attenuated HIV-1 Nef But Not Vpu Function in a Cohort of Rwandan Long-Term SurvivorsGisele Umviligihozo, Jaclyn K Mann, Steven W Jin, et al.
Human Vaccines & Immunotherapeutics|December 31, 2013
Long-term follow-up of study participants from prophylactic HIV vaccine clinical trials in AfricaClaudia Schmidt, Walter Jaoko, Gloria Omosa-Manyonyi, et al.
Plos One|January 10, 2008
Regional differences in prevalence of HIV-1 discordance in Africa and enrollment of HIV-1 discordant couples into an HIV-1 prevention trialJairam R Lingappa, Barrot Lambdin, Elizabeth Ann Bukusi, et al.
Journal of Virology|May 18, 2007
Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infectionHayley Crawford, Julia G Prado, Alasdair Leslie, et al.
Scientific Reports|February 4, 2022
Author Correction: Randomised feasibility study of prehospital recognition and antibiotics for emergency patients with sepsis (PhRASe)Jenna Jones, Susan Allen, Jan Davies, et al.
AIDS Research and Human Retroviruses|June 10, 2005
Viral dynamics and CD4+ T cell counts in subtype C human immunodeficiency virus type 1-infected individuals from southern AfricaClive M Gray, Carolyn Williamson, Helba Bredell, et al.
Scientific Reports|September 21, 2021
Randomised feasibility study of prehospital recognition and antibiotics for emergency patients with sepsis (PhRASe)Jenna Jones, Susan Allen, Jan Davies, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2021
A Stronger Innate Immune Response During Hyperacute Human Immunodeficiency Virus Type 1 (HIV-1) Infection Is Associated With Acute Retroviral SyndromeAmin S Hassan, Jonathan Hare, Kamini Gounder, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2004
Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern AfricaAgatha M Masemola, Tumelo N Mashishi, Greg Khoury, et al.
Journal of Virology|May 8, 2020
Differential Vpu-Mediated CD4 and Tetherin Downregulation Functions among Major HIV-1 Group M SubtypesGisele Umviligihozo, Kyle D Cobarrubias, Sandali Chandrarathna, et al.
Pageof 22

Showing results (191-200 of 220) with videos related to

Sort By:
Pageof 22
Frontiers in Virology (Lausanne, Switzerland)|August 19, 2022
Attenuated HIV-1 Nef But Not Vpu Function in a Cohort of Rwandan Long-Term SurvivorsGisele Umviligihozo, Jaclyn K Mann, Steven W Jin, et al.
Human Vaccines & Immunotherapeutics|December 31, 2013
Long-term follow-up of study participants from prophylactic HIV vaccine clinical trials in AfricaClaudia Schmidt, Walter Jaoko, Gloria Omosa-Manyonyi, et al.
Plos One|January 10, 2008
Regional differences in prevalence of HIV-1 discordance in Africa and enrollment of HIV-1 discordant couples into an HIV-1 prevention trialJairam R Lingappa, Barrot Lambdin, Elizabeth Ann Bukusi, et al.
Journal of Virology|May 18, 2007
Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infectionHayley Crawford, Julia G Prado, Alasdair Leslie, et al.
Scientific Reports|February 4, 2022
Author Correction: Randomised feasibility study of prehospital recognition and antibiotics for emergency patients with sepsis (PhRASe)Jenna Jones, Susan Allen, Jan Davies, et al.
AIDS Research and Human Retroviruses|June 10, 2005
Viral dynamics and CD4+ T cell counts in subtype C human immunodeficiency virus type 1-infected individuals from southern AfricaClive M Gray, Carolyn Williamson, Helba Bredell, et al.
Scientific Reports|September 21, 2021
Randomised feasibility study of prehospital recognition and antibiotics for emergency patients with sepsis (PhRASe)Jenna Jones, Susan Allen, Jan Davies, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2021
A Stronger Innate Immune Response During Hyperacute Human Immunodeficiency Virus Type 1 (HIV-1) Infection Is Associated With Acute Retroviral SyndromeAmin S Hassan, Jonathan Hare, Kamini Gounder, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2004
Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern AfricaAgatha M Masemola, Tumelo N Mashishi, Greg Khoury, et al.
Journal of Virology|May 8, 2020
Differential Vpu-Mediated CD4 and Tetherin Downregulation Functions among Major HIV-1 Group M SubtypesGisele Umviligihozo, Kyle D Cobarrubias, Sandali Chandrarathna, et al.
Pageof 22